Fabrication of biodegradable PEG–PLA nanospheres for solubility, stabilization, and delivery of curcumin

Abstract Curcumin is an effective and safe anticancer agent, and also known to induce vasodilation, but its hydrophobicity limits its clinical application. In this study, a simple emulsion method was developed to prepare biodegradable poly (ethylene glycol)–poly (lactic acid) (PEG–PLA) nanospheres to encapsulate curcumin to improve its solubility and stability. The nanoparticle size was around 150 nm with a narrow size distribution. Fluorescence microscopy showed that curcumin encapsulated PEG-PLA nanospheres were taken up rapidly by Hela and MDA-MB-231 cancer cells. This novel nanoparticulate carrier may improve the bioavailability of curcumin without affecting its anticancer properties.

[1]  A. Akbarzadeh,et al.  A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line , 2016, Artificial cells, nanomedicine, and biotechnology.

[2]  G. Verreck,et al.  Preclinical and Clinical Studies , 2015 .

[3]  G. Zhai,et al.  Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting. , 2014, Colloids and surfaces. B, Biointerfaces.

[4]  K. Chennazhi,et al.  Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. , 2014, Biochimica et biophysica acta.

[5]  K. Kehn-Hall,et al.  Curcumin inhibits Rift Valley fever virus replication in human cells. , 2014, The Journal of Biological Chemistry.

[6]  S. Mahadevan,et al.  Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells. , 2014, Biochimica et biophysica acta.

[7]  Yuquan Wei,et al.  Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles. , 2013, Journal of materials chemistry. B.

[8]  T. Chang,et al.  Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase , 2013, Artificial cells, nanomedicine, and biotechnology.

[9]  Yu Qiu,et al.  Cellular internalization pathway and transcellular transport of pegylated polyester nanoparticles in Caco-2 cells. , 2013, International journal of pharmaceutics.

[10]  N. N. Hoai,et al.  In Vitro Apoptosis Enhancement of Hep-G2 Cells by PLA–TPGS and PLA–PEG Block Copolymer Encapsulated Curcumin Nanoparticles , 2013 .

[11]  Xinguo Jiang,et al.  Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. , 2012, International journal of pharmaceutics.

[12]  R. Pochampally,et al.  Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[13]  N. Okudan,et al.  Curcumin increases vasodilatory effect of cilostazol in diabetic rat aorta. , 2012, Indian journal of experimental biology.

[14]  F. Aqil,et al.  Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention , 2011, Cancer Prevention Research.

[15]  A. Singer,et al.  Curcumin mediates both dilation and constriction of peripheral arterioles via adrenergic receptors , 2011, The Journal of investigative dermatology.

[16]  S. Patumraj,et al.  Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition , 2010, BMC complementary and alternative medicine.

[17]  C. Mohanty,et al.  Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. , 2010, Nanomedicine.

[18]  B. Aggarwal,et al.  Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. , 2010, Biochemical pharmacology.

[19]  Yue-liang Shen,et al.  Curcumin ameliorates high glucose‐induced acute vascular endothelial dysfunction in rat thoracic aorta , 2009, Clinical and experimental pharmacology & physiology.

[20]  B. Aggarwal,et al.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.

[21]  R. Lai,et al.  Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. , 2008, Journal of biomedical materials research. Part A.

[22]  Razelle Kurzrock,et al.  Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer , 2008, Clinical Cancer Research.

[23]  R. Rodriguez,et al.  Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. , 2008, Cancer letters.

[24]  B. Aggarwal,et al.  Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.

[25]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[26]  R. H. Scofield,et al.  Improving the solubility and pharmacological efficacy of curcumin by heat treatment. , 2007, Assay and drug development technologies.

[27]  W. Tiyaboonchai,et al.  Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. , 2007, International journal of pharmaceutics.

[28]  G. Ouyang,et al.  Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells , 2006, Cell biology international.

[29]  A. Vila,et al.  Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[30]  K. Du,et al.  Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects , 2004, Science.

[31]  Z. Su,et al.  W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[32]  R. Orlowski,et al.  Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. , 2002, Cancer research.

[33]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[34]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[35]  H. Tønnesen,et al.  Studies on curcumin and curcuminoids , 1985, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.

[36]  J. Friedman,et al.  Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[37]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[38]  M. Pirmohamed,et al.  Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance , 2004 .

[39]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[40]  C. Rock,et al.  Bmc Complementary and Alternative Medicine Dose Escalation of a Curcuminoid Formulation , 2022 .